-
Think twice before filing in the UPC if you foresee a private-prior-use defense under German law: further Fujifilm v. Kodak analysis
Read more: Think twice before filing in the UPC if you foresee a private-prior-use defense under German law: further Fujifilm v. Kodak analysisThere are opportunities in the UPC, but sometimes there can be a downside. The CoA’s Fujifilm v. Kodak decision lays out a permissive approach to (German) prior use in evidentiary, substantive, and procedural terms.
-
Incyte acquires bleeding-disorder biotech Vega Therapeutics as Jakafi patent cliff looms
Read more: Incyte acquires bleeding-disorder biotech Vega Therapeutics as Jakafi patent cliff loomsIncyte will pay $1.25 billion upfront for Vega Therapeutics, with up to $750 million more in sales milestones. The $2.4 billion-a-year drug loses U.S. exclusivity in December 2028 after a pediatric extension.
-
UPC Roundup (1 week): security decisions (no SME bonus, parent company doesn’t count); two failed infringement lawsuits; more
Read more: UPC Roundup (1 week): security decisions (no SME bonus, parent company doesn’t count); two failed infringement lawsuits; moreThis is a summary of developments in and around the UPC in the calendar week of June 1, 2026.
-
BREAKING: Avanci signed up four Chinese automakers as licensees between early April and now; 11 Chinese licensees in total, 17 contracts
Read more: BREAKING: Avanci signed up four Chinese automakers as licensees between early April and now; 11 Chinese licensees in total, 17 contractsSince the last such announcement on March 31, four more Chinese automakers have taken an Avanci license. Geely is undoubtedly one of them.
-
Neither does the UPC need Spain and Poland — nor vice versa; but Ireland is an unfortunate outlier among non-members
Read more: Neither does the UPC need Spain and Poland — nor vice versa; but Ireland is an unfortunate outlier among non-membersThe reluctance of Poland and Spain to join the UPC is overemphasized in the UPC docket distribution debate. Realistically, only some individuals — but not the countries in question — have something to gain from UPC membership.
-
NPEs seeking U.S. patent injunctions won’t benefit from Judge Gilstrap’s clearly erroneous finding of irreparable harm in Collision v. Samsung
Read more: NPEs seeking U.S. patent injunctions won’t benefit from Judge Gilstrap’s clearly erroneous finding of irreparable harm in Collision v. SamsungSome defense-focused patent litigators warn against the potential fallout from Judge Gilstrap’s Collision v. Samsung decision while enforcement-oriented lawyers see opportunities for NPEs. But the part that gets everyone excited is clear legal error.
-
UPC grants Samsung two-week extension to comment on court’s proposal for settlement with ZTE, Samsung risks unwillingness finding
Read more: UPC grants Samsung two-week extension to comment on court’s proposal for settlement with ZTE, Samsung risks unwillingness findingSamsung’s request for an extension of time by a full month appeared unreasonable (if not outrageous) to the UPC’s Mannheim LD.
-
Vote to replace Access Advance with Sisvel as VCL HEVC/VVC pool administrator fails: less than 1/3 of licensors in favor
Read more: Vote to replace Access Advance with Sisvel as VCL HEVC/VVC pool administrator fails: less than 1/3 of licensors in favorA vote reportedly initiated by Harold Barrault, Vice President and Head of Patent Licensing at Orange (a major pool licensor), has failed to reach the necessary majority to put Sisvel in charge of Access Advance’s VCL HEVC/VVC patent pool.


